JPH0759849A - Blood filter in common use as blood dialyzer - Google Patents

Blood filter in common use as blood dialyzer

Info

Publication number
JPH0759849A
JPH0759849A JP23589893A JP23589893A JPH0759849A JP H0759849 A JPH0759849 A JP H0759849A JP 23589893 A JP23589893 A JP 23589893A JP 23589893 A JP23589893 A JP 23589893A JP H0759849 A JPH0759849 A JP H0759849A
Authority
JP
Japan
Prior art keywords
blood
dialyzer
housing
length
hollow fiber
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP23589893A
Other languages
Japanese (ja)
Other versions
JP2961481B2 (en
Inventor
Takeshi Shibata
猛 柴田
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Scitec KK
Original Assignee
Scitec KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scitec KK filed Critical Scitec KK
Priority to JP23589893A priority Critical patent/JP2961481B2/en
Publication of JPH0759849A publication Critical patent/JPH0759849A/en
Application granted granted Critical
Publication of JP2961481B2 publication Critical patent/JP2961481B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Abstract

PURPOSE:To make it possible to obtain blood dialysis and blood filter function by joining a blood dialyzer and a blood filter. CONSTITUTION:The housing H of the dialyzer D of a hollow yarn type is formed in its shape to a length of about 10 to 15 times and more particularly about 12 times the bore 1. The hollow yarn F having excellent material permeability exists therein. The hollow yarn is introduced between a blood inlet 1 and blood outlet 2 disposed at both ends of the housing H and is formed in its shape to a length of about 10 to 15 times and more particularly about 12 times the diameter 1. As a result, the blood filtration which is heretofore executable only with the conventional device to be exclusively in an ordinary blood dialyzer can be executed; in addition, the need for a large volume of replenishing of a transfusion agent is eliminated. Consequently, the easy removal of middle- and high-mol.wt. materials without spending specific costs is possible and further, the ability to remove low-mol.wt. materials is improved and blood clotting is prevented.

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【産業上の利用分野】本発明は、広くは医療機器に関す
るものであり、特に中空糸型のダイアライザーに関する
ものである。就中、1台の機器で血液透析器及び血液濾
過器の両方の機能を備えるダイアライザーに関するもの
である。
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates generally to medical equipment, and more particularly to a hollow fiber type dialyzer. In particular, the present invention relates to a dialyzer having the functions of both a hemodialyzer and a hemofilter with one device.

【0002】[0002]

【従来の技術】人間の体内の血液中の老廃物を人工的に
除去する方式としては、透析(濃度勾配)の原理に基づ
いた透析型人工腎臓(血液透析器)が一般的であるが、
濾過型人工腎臓(血液濾過器)も中・高分子量物質除去
の有力な手段として一部で利用されている。
2. Description of the Related Art A dialysis-type artificial kidney (hemodialyzer) based on the principle of dialysis (concentration gradient) is generally used as a method for artificially removing waste products from blood in the human body.
Filtered artificial kidneys (blood filters) are also used in some areas as a powerful means of removing medium and high molecular weight substances.

【0003】[0003]

【発明が解決しようとする課題】血液透析は低分子量物
質の除去には優れているが、中・高分子量物質の除去能
力が劣る。一方、血液濾過は中・高分子量物質の除去に
は優れているが、低分子量物質の除去能は劣る。また、
血液濾過では、10〜20リットルの輸液剤の大量補液
が必要である。さらに、濾過量と補液量のバランスを適
切にコントロールするための装置が必要となり、治療上
の操作は煩雑で治療費も高額となる。
Although hemodialysis is excellent in removing low molecular weight substances, it is inferior in the ability to remove medium and high molecular weight substances. On the other hand, hemofiltration is excellent in removing medium and high molecular weight substances, but inferior in removing low molecular weight substances. Also,
Hemofiltration requires a large volume of infusion of 10-20 liters of infusion. Further, a device for appropriately controlling the balance between the filtration amount and the replacement fluid amount is required, and the operation for treatment is complicated and the treatment cost is high.

【0004】[0004]

【課題を解決するための手段】本発明にかかる血液透析
器兼血液濾過器は、以上の問題点に鑑みて、血液透析と
血液濾過の長所を生かし、それぞれの短所をなくしたも
のである。すなわち、従来、血液透析と血液濾過はそれ
ぞれ専用の中空糸と装置が必要であった。本発明では、
血液透析用装置に本発明の血液透析濾過器を用い、血液
透析と血液濾過性能が得られるが、従来の血液濾過のご
とき大量の補液を必要としないものである。
In view of the above problems, the hemodialyzer / hemofilter according to the present invention makes use of the advantages of hemodialysis and hemofiltration and eliminates their respective disadvantages. That is, conventionally, hemodialysis and hemofiltration each require a dedicated hollow fiber and device. In the present invention,
Although the hemodialysis filter of the present invention is used as a hemodialysis device to obtain hemodialysis and hemofiltration performance, it does not require a large amount of replacement fluid as in conventional hemofiltration.

【0005】具体的には、中空糸型血液透析器に物質透
過性に優れた膜を使い、血液の流れに対する透析器の内
部抵抗を従来の血液透析器より大幅に高めることによ
り、ダイアライザーの入口側では積極的に濾過を行な
い、ダイアライザーの出口側では逆濾過により水分を血
中へ戻し濾過量とのバランスをとる。このため輸液剤の
補液が必要でなくなり、従来の血液透析装置で血液透析
と血液濾過が同時に行えるものとなった。
Specifically, a membrane having excellent substance permeability is used in the hollow fiber hemodialyzer, and the internal resistance of the dialyzer to the flow of blood is greatly increased as compared with the conventional hemodialyzer, so that the inlet of the dialyzer is increased. At the outlet side of the dialyzer, water is returned to the blood by back filtration to balance the filtration amount. For this reason, it is no longer necessary to replenish the infusion solution, and it has become possible to perform hemodialysis and hemofiltration simultaneously with a conventional hemodialysis apparatus.

【0006】かようにして、中空糸型ダイアライザーの
血液系および透析液系の内部抵抗を高めるために、ダイ
アライザーの内径と長さの比率を従来のものが1:5程
度のものであったのを、1:10以上にするものであ
る。その結果、ダイアライザーの断面積は従来のものよ
り小さくすることができ、その長さは従来のものより長
くすることができ、その内部抵抗は非常に増える。この
結果、ダイアライザーの入口側の圧は高く、出口側の圧
は低くなり濾過と逆濾過が大幅に起こることになる。
Thus, in order to increase the internal resistance of the blood system and dialysate system of the hollow fiber dialyzer, the conventional dialyzer had a ratio of the inner diameter to the length of about 1: 5. Is 1:10 or more. As a result, the cross-sectional area of the dialyzer can be made smaller than the conventional one, its length can be made longer than the conventional one, and its internal resistance is greatly increased. As a result, the pressure on the inlet side of the dialyzer is high, and the pressure on the outlet side is low, so that filtration and back filtration occur significantly.

【0007】以下に、本発明にかかる血液透析器兼血液
濾過器の具体的な構成を詳細に記載する。これは、ま
ず、中空糸型ダイアライザーにおいて、ダイアライザー
のハウジングがある。このハウジングは、その形状がそ
の内径1に対しその長さを10〜15程度特に12程度
の比率にしたものである。そして、中空糸がある。この
中空糸は、ハウジンクの両端に設けられた血液入口と血
液出口間に挿入されたものであってその形状がその直径
1に対しその長さを10〜15程度特に12程度の比率
にしたものである。
The specific construction of the hemodialyzer / hemofilter according to the present invention will be described in detail below. First, in the hollow fiber type dialyzer, there is a dialyzer housing. The shape of the housing is such that the length is about 10 to 15 and especially about 12 with respect to the inner diameter 1. And there is a hollow fiber. This hollow fiber is inserted between the blood inlet and the blood outlet provided at both ends of the housing, and its shape is such that the length is about 10 to 15 and especially about 12 to the diameter thereof. Is.

【0008】[0008]

【作用】本発明にかかる血液透析器兼血液濾過器は、以
上のごとき構成に為したゆえに以下のごとき作用が生じ
た。すなわち、ダイアライザー内の入口側の中空糸の中
の血液の圧が高くなり、逆にその出口側の中空糸の中の
血液の圧は低くなる。それゆえに、一つのダイアライザ
ーの入口側では積極的に血液の濾過を行ない、そのダイ
アライザーの出口側では逆濾過により、透析液中の水分
を血中へ戻し、濾過量とのバランスをとるものである。
The hemodialyzer / hemofilter according to the present invention has the following effects because it has the above-described configuration. That is, the pressure of blood in the hollow fiber on the inlet side in the dialyzer increases, and conversely, the pressure of blood in the hollow fiber on the outlet side decreases. Therefore, blood is actively filtered on the inlet side of one dialyzer, and water in the dialysate is returned to the blood by counter filtration on the outlet side of the dialyzer to balance the filtration amount. .

【0009】一方、血液透析として低分子量物質の除去
が行なわれ、血液濾過として中・高分子量物質の除去が
なされる。
On the other hand, low molecular weight substances are removed by hemodialysis, and medium and high molecular weight substances are removed by hemofiltration.

【0010】[0010]

【実施例】以下に、本発明にかかる血液透析器兼血液濾
過器をその一実施例を用いて詳細にこの内容を述べる。
これは、まず、中空糸型ダイアライザーDにおいて、ダ
イアライザーのハウジングHがある。このハウジングH
は、その形状が、その内径1に対してその長さを10〜
15程度、特に12程度の比率にしたものである。
The contents of a hemodialyzer / hemofilter according to the present invention will be described below in detail with reference to an embodiment thereof.
First, in the hollow fiber type dialyzer D, there is a housing H of the dialyzer. This housing H
Has a shape whose length is 10 to 10 with respect to its inner diameter 1.
The ratio is about 15, especially about 12.

【0011】そして、物質透過性に優れた中空糸Fがあ
る。この中空糸Fは、上記のハウジンクHの両端に設け
られた血液入口1と血液出口2間に挿入されたものであ
ってその形状がその直径1に対しその長さを10〜15
程度特に12程度の比率にしたものである。一方、透析
液は、透析液入口3から入り、透析液出口4から出てい
く。そして、当然のことながら、透析液は逆濾過に対応
できるように、透析液の清浄化手段が充分講じられてい
なければならない。
Then, there is a hollow fiber F having excellent substance permeability. The hollow fiber F is inserted between the blood inlet 1 and the blood outlet 2 provided at both ends of the above-mentioned housing H, and its shape has a diameter of 1 and a length of 10 to 15.
The ratio is about 12 in particular. On the other hand, the dialysate enters through the dialysate inlet 3 and exits through the dialysate outlet 4. As a matter of course, the dialysate must be sufficiently cleaned so that it can be subjected to back filtration.

【0012】[0012]

【発明の効果】本発明にかかる血液透析器兼血液濾過器
による血液透析は以上のごとくなしたゆえに、以下のご
とき多大な効果が生じた。まず、従来は専用の装置でし
か実行できなかった血液濾過が、通常の血液透析装置を
改良したもののみで実行でき、しかも輸液剤の補液の必
要がなくなった。その結果、中・高分子量物質の除去が
特別に費用をかけず容易に行えるようになった。さらに
低分子量物質の除去能も向上した。
Since the hemodialysis by the hemodialyzer / hemofilter according to the present invention is performed as described above, the following great effects are brought about. First, hemofiltration, which was conventionally only possible with a dedicated device, can be performed only with an improved hemodialysis device, and there is no need for fluid replacement. As a result, it has become possible to easily remove the medium and high molecular weight substances without any special cost. Furthermore, the ability to remove low molecular weight substances was also improved.

【0013】以上のごとく、中空糸型血液透析兼血液濾
過器において、その形状が内径1に対し中空糸の長さを
10以上としたゆえに、このダイアライザーの血液入口
側の圧が200mmHgの時に、血液出口側の圧は20mmHg
であった。一方、透析液は、入口圧が100mmHgの時
に、出口圧は0mmHgであった。このため、ダイアライザ
ーの血液の入口側では血中の水分は透析液側へ濾過さ
れ、一方出口側では、透析液側より血中へ逆濾過が起き
る。かくして、血液濾過により従来の血液透析より中・
高分子量物質の除去能は大幅に向上した。
As described above, in the hollow fiber hemodialysis / hemofilter, since the shape has a hollow fiber length of 10 or more with respect to an inner diameter of 1, when the pressure at the blood inlet side of this dialyzer is 200 mmHg, The pressure on the blood outlet side is 20 mmHg
Met. On the other hand, the dialysate had an outlet pressure of 0 mmHg when the inlet pressure was 100 mmHg. For this reason, water in the blood is filtered toward the dialysate side at the blood inlet side of the dialyzer, while reverse filtration occurs from the dialysate side into the blood at the outlet side. Thus, by hemofiltration, it is more effective than conventional hemodialysis.
The ability to remove high molecular weight substances was greatly improved.

【0014】一方、ダイアライザーの内径の断面積を従
来のものより細くし、その長さを長くできるように為し
た結果、血液及び透析液の流速が上がり透析膜の物質拡
散抵抗が少なくなり低分子量物質の除去能も向上した。
なお、血液の流速が上がることにより、血液の凝固も防
止できた。また、当然のことながら、透析液は逆濾過に
対応できるように、透析液の清浄化手段が充分講じられ
ていなければならない。
On the other hand, the cross-sectional area of the inner diameter of the dialyzer is made smaller than that of the conventional one so that the length of the dialyzer can be made longer. As a result, the flow rate of blood and dialysate is increased, and the resistance to substance diffusion of the dialysis membrane is reduced, resulting in low molecular weight The ability to remove substances was also improved.
The blood coagulation could be prevented by increasing the blood flow velocity. In addition, as a matter of course, the dialysate must be sufficiently cleaned so that it can be subjected to back filtration.

【0015】さらに、濾過量と補液量のバランスを適切
にコントロールするための装置が必要でなくなり、治療
上の操作は煩雑でなく、その結果その治療費も低額のも
のととなった。
Furthermore, a device for appropriately controlling the balance between the filtration amount and the replacement fluid amount is not required, the operation for treatment is not complicated, and as a result, the treatment cost is low.

【図面の簡単な説明】[Brief description of drawings]

【図1】本発明にかかる血液透析器兼血液濾過器の側面
図である。
FIG. 1 is a side view of a hemodialyzer / hemofilter according to the present invention.

【図2】本発明にかかる血液透析器兼血液濾過器内での
血液からの水分濾過と血液への水分の逆濾過を示したグ
ラフである。
FIG. 2 is a graph showing water filtration from blood and back filtration of water into blood in the hemodialyzer / hemofilter according to the present invention.

【符号の説明】[Explanation of symbols]

1 血液入口 2 血液出口 3 透析液入口 4 透析液出口 D ダイアライザー F 中空糸 H ハウジング 1 blood inlet 2 blood outlet 3 dialysate inlet 4 dialysate outlet D dialyzer F hollow fiber H housing

Claims (1)

【特許請求の範囲】[Claims] 【請求項1】中空糸型ダイアライザーにおいて、その形
状がその内径1に対しその長さを10〜15程度特に1
2倍程度の比率にしたダイアライザーのハウジング、該
ダイアライザーのハウジンクの両端に設けられた血液入
口と血液出口間に挿入されたものであってその形状がそ
の直径1に対しその長さを10〜15程度特に12程度
の比率の中空糸、より構成されることを特徴とした血液
透析器兼血液濾過器。
1. A hollow fiber type dialyzer whose shape has a length of about 10 to 15 with respect to an inner diameter of 1, especially 1.
A housing of a dialyzer having a ratio of about 2 times, which is inserted between a blood inlet and a blood outlet provided at both ends of a housing of the dialyzer, the shape of which is 10 to 15 in length with respect to its diameter. A hemodialyzer / hemofilter, which is characterized by comprising hollow fibers having a ratio of about 12, in particular.
JP23589893A 1993-08-30 1993-08-30 Hemodialyzer and hemofilter Expired - Fee Related JP2961481B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP23589893A JP2961481B2 (en) 1993-08-30 1993-08-30 Hemodialyzer and hemofilter

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP23589893A JP2961481B2 (en) 1993-08-30 1993-08-30 Hemodialyzer and hemofilter

Publications (2)

Publication Number Publication Date
JPH0759849A true JPH0759849A (en) 1995-03-07
JP2961481B2 JP2961481B2 (en) 1999-10-12

Family

ID=16992879

Family Applications (1)

Application Number Title Priority Date Filing Date
JP23589893A Expired - Fee Related JP2961481B2 (en) 1993-08-30 1993-08-30 Hemodialyzer and hemofilter

Country Status (1)

Country Link
JP (1) JP2961481B2 (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7128836B2 (en) 2004-03-08 2006-10-31 Potito De Paolis Dialysis device
US7524417B2 (en) 2002-12-26 2009-04-28 Nipro Corporation Dialyzer and method for manufacturing the same
WO2016024510A1 (en) * 2014-08-11 2016-02-18 国立大学法人大阪大学 Dialyzer, liposome manufacturing device, concentration controller for fluid to be dialyzed, and method for controlling concentration of fluid to be dialyzed

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1344542B1 (en) 2002-03-14 2007-05-16 Nipro Corporation Dialyzer and method for manufacturing the same
JP4992106B2 (en) 2004-08-06 2012-08-08 旭化成メディカル株式会社 Polysulfone hemodialyzer

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7524417B2 (en) 2002-12-26 2009-04-28 Nipro Corporation Dialyzer and method for manufacturing the same
US7128836B2 (en) 2004-03-08 2006-10-31 Potito De Paolis Dialysis device
WO2016024510A1 (en) * 2014-08-11 2016-02-18 国立大学法人大阪大学 Dialyzer, liposome manufacturing device, concentration controller for fluid to be dialyzed, and method for controlling concentration of fluid to be dialyzed
JPWO2016024510A1 (en) * 2014-08-11 2017-07-13 国立大学法人大阪大学 Dialysis apparatus, liposome production apparatus, and liposome production method
US11633699B2 (en) 2014-08-11 2023-04-25 Osaka University Dialyzer, liposome producing apparatus, and liposome producing method

Also Published As

Publication number Publication date
JP2961481B2 (en) 1999-10-12

Similar Documents

Publication Publication Date Title
JP5543049B2 (en) Method of operating blood purification apparatus and blood purification apparatus
US5858238A (en) Salvage of autologous blood via selective membrane/sorption technologies
US5011607A (en) Hemodiafiltration system
US7169303B2 (en) Sorbent reactor for extracorporeal blood treatment systems, peritoneal dialysis systems, and other body fluid treatment systems
US7182867B2 (en) Shear-enhanced systems and methods for removing waste materials and liquid from the blood
KR100604460B1 (en) Hemodiafiltration/hemofiltration cartridges
CA2180455A1 (en) Hemofiltration and plasmafiltration devices and methods
JP3011463B2 (en) Therapeutic blood purification apparatus and method for producing transfusion for hemodiafiltration (HDF)
SU553912A3 (en) Artificial kidney
ATE352332T1 (en) METHOD AND DEVICE FOR PERFORMING CONTROLLED ULTRAFILTRATION OF DIALYSATE DURING HEMODIALYSIS
KR20150097785A (en) Haemodiafiltration method
JP2003265597A (en) Hemodialysis filter and filtering device
JPH0759849A (en) Blood filter in common use as blood dialyzer
EP0233848A2 (en) An improved filtering device, particularly for treating kidney insufficiencies
JP3858260B2 (en) Blood purification equipment
JPH08126700A (en) Apparatus for switching direction of bloodstream to blood filter and method therefor
EP1002566B1 (en) Filter for adsorbing heparin and/or endotoxins in plasma and/or blood
JP2005118506A (en) On-line massive fluid replacement type hemodialyzer
JP2002095740A (en) Method for returning residual blood in blood circuit and device for blood purification
JPS6362B2 (en)
JP2894475B2 (en) Hemodialysis machine using hollow fiber membrane
Ronco et al. A new blood module for continuous renal replacement therapies
JPS596663B2 (en) Multi-stage filtration/reabsorption artificial kidney
Nosé et al. Plasma filtration detoxification on hepatic patients: its optimal operating conditions
JP4237534B2 (en) Blood purifier

Legal Events

Date Code Title Description
R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

FPAY Renewal fee payment (prs date is renewal date of database)

Free format text: PAYMENT UNTIL: 20070806

Year of fee payment: 8

FPAY Renewal fee payment (prs date is renewal date of database)

Free format text: PAYMENT UNTIL: 20080806

Year of fee payment: 9

LAPS Cancellation because of no payment of annual fees